Safety and Immunogenicity of a novel three-dose recombinant nanoparticle rabies G protein vaccine administered as simulated post exposure immunization: A randomized, comparator controlled, multicenter, phase III clinical study

• Main Authors: Ravish H S (Author), Akash Khobragade (Author), Durga Satapathy (Author), Monica Gupta (Author), Surendra Kumar (Author), Vinay Bhomia (Author), Ramasubramanian V (Author), Maharshi Desai (Author), Ashok Dilipkumar Agrawal (Author)
• Format: Book
• Published: Taylor & Francis Group, 2021-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background Rabies vaccines are lifesaving in human post animal exposure. However, the compliance to the complete course of vaccine is found to be only 60%. Hence, there is a need for safe and immunogenic, shorter course vaccine that can enhance the compliance and effectively prevent the disease. Obj...